|
T42.2X5S |
Adverse effect of succinimides and oxazolidinediones, sequela |
| POA Exempt |
| Billable Code | is a billable ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. |
| GEMS |
| ICD-10-CM T42.2X5S converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM 909.5 Late effect of adverse effect of drug, medicinal or biological substance |
| GEMS |
| ICD-10-CM T42.2X5S converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM E936.2 Succinimides causing adverse effects in therapeutic use |
| GEMS |
| ICD-10-CM T42.2X5S converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM 909.5 Late effect of adverse effect of drug, medicinal or biological substance |
| GEMS |
| ICD-10-CM T42.2X5S converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM E936.0 Oxazolidine derivatives causing adverse effects in therapeutic use |
| ICD-10-CM T42.2X5Sis grouped within Diagnostic Related Group(s) (MS-DRG v30.0) |
| 922 OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC
|
| 923 OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC
|
| Alternate Description |
| Poisoning by succinimides and oxazolidinediones NOS |
